GHRP-6 — Safety, Research, Risks & Legal Status

Not medical advice. GHRP-6 is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.

Also known as	growth hormone releasing peptide 6, His-DTrp-Ala-Trp-DPhe-Lys-NH2
Category	Peptide
not_fda_approved	Research chemical only; never approved as a human therapeutic
strong_appetite_effect	More pronounced appetite stimulation than most other GHS compounds
wada_banned	Prohibited at all times in sport
US legal status	GHRP-6 is not approved by the FDA for human use in the United States and is sold as a research chemical labeled not for human consumption. It has no approved medical indication. It is prohibited at all times in sport under the WADA list as a growth hormone secretagogue.

What is GHRP-6?

GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that acts on the ghrelin/GHS receptor to stimulate pituitary release of growth hormone. It also strongly stimulates appetite. GHRP-6 was one of the first synthetic GHS compounds discovered and remains widely studied as a probe of GH regulation.

How it works

GHRP-6 is a ligand for the growth hormone secretagogue receptor (GHS-R), also known as the ghrelin receptor. Binding to GHS-R triggers intracellular signaling in somatotroph cells that stimulates GH synthesis and release. GHRP-6 also acts on ghrelin receptors in the gastrointestinal tract and hypothalamus, accounting for its pronounced appetite-stimulating effects. Unlike GHRH, it does not require an intact GHRH pathway and works through a distinct mechanism.

Background & history

GHRP-6 was developed in the late 1980s and early 1990s as part of a research effort to identify non-peptide GH secretagogues. It was one of the first synthetic peptide GHS compounds and became a key research tool for understanding the ghrelin-GHS-R axis. Animal and early human studies suggested potential therapeutic applications, but it was never approved as a drug and remains a research chemical.

What the research says

Research, much of it from animal models and small early human studies, suggests GHRP-6 increases growth hormone secretion and markedly stimulates appetite via ghrelin-receptor activation. Robust modern human clinical evidence for therapeutic benefit is limited, and it is not an approved therapy. Some reports suggest potential cytoprotective effects, but these are not well established in human populations.

Reported effects

Reported increase in growth hormone secretion
Strongly reported appetite stimulation
Studied increases in IGF-1 levels
Reported effects on cytoprotection in early animal research
Studied direct effects on gut hormone secretion
Reported stimulation of prolactin and cortisol secretion

Dosing & administration (informational)

In animal and early human research, GHRP-6 has been administered intravenously or subcutaneously in doses ranging from 1 to 100 micrograms per kilogram of body weight, with GH peaks occurring within 15 to 60 minutes post-injection. Some studies used repeated daily injections to examine cumulative effects.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

Injection carries risks of pain, bruising, infection, and injection-site reactions without sterile technique
Elevated growth hormone and IGF-1 can promote insulin resistance, water retention, and joint pain
Increased GH and IGF-1 are a theoretical cancer concern, since IGF-1 acts as a growth signal
Prohibited at all times in sport under the WADA list
Sold as a research chemical with no quality assurance, so contamination, mislabeling, and impurity are real risks
Marked appetite stimulation may be problematic for metabolic control and dietary goals

Drug & supplement interactions

Somatostatin suppresses GHRP-6-induced GH release
Concurrent GH secretagogues (GHRH, GHRP-2, hexarelin) may have synergistic or unexpected combined effects
Opioid antagonists may blunt appetite-stimulating effects
Dopamine and adrenergic function influence GH response intensity

Who should avoid it

Active malignancy or cancer history (IGF-1 elevation risk)
Uncontrolled or poorly managed diabetes
Appetite-control disorders or body-image concerns (marked appetite stimulation)
Sleep apnea (GH elevation may exacerbate)
Severe hepatic or renal impairment

How it is commonly combined

GHRP-6 is sometimes combined with GHRH or other GHRP compounds in research contexts to achieve enhanced or synergistic GH secretion. Such combinations are not well-studied in humans and carry compounded risks.

Legal & regulatory. GHRP-6 is not approved by the FDA for human use in the United States and is sold as a research chemical labeled not for human consumption. It has no approved medical indication. It is prohibited at all times in sport under the WADA list as a growth hormone secretagogue.

Quality & harm reduction

R
e
q
u
i
r
e
a
t
h
i
r
d
-
p
a
r
t
y
c
e
r
t
i
f
i
c
a
t
e
o
f
a
n
a
l
y
s
i
s
(
C
O
A
)
b
e
f
o
r
e
t
r
u
s
t
i
n
g
a
n
y
p
r
o
d
u
c
t
.
L
o
o
k
f
o
r
H
P
L
C
a
n
d
m
a
s
s
s
p
e
c
t
r
o
m
e
t
r
y
d
a
t
a
c
o
n
f
i
r
m
i
n
g
i
d
e
n
t
i
t
y
a
n
d
p
u
r
i
t
y
.
E
n
d
o
t
o
x
i
n
(
L
A
L
)
t
e
s
t
i
n
g
i
s
i
m
p
o
r
t
a
n
t
f
o
r
a
n
y
p
e
p
t
i
d
e
i
n
t
e
n
d
e
d
f
o
r
i
n
j
e
c
t
i
o
n
.
U
s
e
s
t
e
r
i
l
e
r
e
c
o
n
s
t
i
t
u
t
i
o
n
a
n
d
c
o
l
d
s
t
o
r
a
g
e
t
o
l
i
m
i
t
d
e
g
r
a
d
a
t
i
o
n
a
n
d
c
o
n
t
a
m
i
n
a
t
i
o
n
.

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options

Frequently asked questions

Why does GHRP-6 make people hungry?

It activates the ghrelin receptor, which is the body's hunger signal, so studies report strong appetite stimulation alongside growth hormone release.

Is GHRP-6 legal to use in the US?

It is not FDA-approved for human use and is sold only as a research chemical not for human consumption. It is also banned in sport.

How much should I inject?

We do not provide human dosing guidance for unapproved research chemicals.

Does GHRP-6 work better than sermorelin?

Both stimulate GH, but GHRP-6 uses the ghrelin-receptor pathway rather than GHRH signaling. GHRP-6 causes stronger appetite stimulation; GHRH-based peptides preserve pituitary feedback more naturally.

Can I combine GHRP-6 with other peptides?

Combining GH secretagogues is not well-studied in humans and increases risks of side effects and unpredictable interactions.

References & further reading

PubMed: GHRP-6 growth hormone secretion ghrelin
PubMed: GHS receptor pharmacology ghrelin
WADA Prohibited List: growth hormone secretagogues
PubMed: GHRP-6 appetite stimulation mechanism
ClinicalTrials.gov: growth hormone secretagogue early studies